CLINICAL_TRIALS
trial_result
· 2016-07-06
Clinical Trial Update: An Evaluation Of PF-03715455 In Moderate To Severe Chronic Obstructive Pulmonary Disease [Phase 2]
Summary
Phase 2 trial evaluating PF-03715455 in moderate-to-severe chronic obstructive pulmonary disease was terminated; results were posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 2 | Status: TERMINATED | Results posted: 2016-07-06